Antiplatelet Agents and Anticoagulants |

Figure 2 : A, Risk for recurrence of venous thromboembolism (VTE). B, Approach to decision making regarding the length of oral anticoagulant therapy in patients with spontaneous VTE. DVT, deep venous thrombosis; INR, international normalized ratio; OCP, oral contraceptive pills; PE, pulmonary embolism.
Detailed guidelines are available.4 Patients who had DVT or PE associated with a transient risk factor (major surgery or trauma) have a low risk for recurrent thrombosis and are classically treated for only 3 months with vitamin K antagonists. Patien ...
|
Individuals |
Groups and Organizations |
Imaging Consult provides access to the most in-depth, authoritative imaging information designed to help physicians quickly make accurate diagnostic decisions, improve procedural skills, and optimize patient outcomes.